BP000140-C021: Recombinant Human Interleukin-17A (IL-17A) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependent induction of IL-6 in primary human foreskin fibroblasts was found to be approximately 2 ug/ml, corresponding to a Specific Activity of 5 x 105 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000140-CYT-102: Recombinant Human Interleukin-17A (IL-17A), HEK Protein
Source: HEK-derived.
The specific activity was determined by the dose-dependent induction of IL-6 secretion from NDHF Adult fibroblasts and is typically 5-25 ug/ml.
Purity: > 95% as obsereved by SDS-PAGE.BP000140-CYT-250: Recombinant Human Interleukin-17A (IL-17A) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependent induction of IL-6 in Hs68 cell line was found to be approximately 2 ug/ml corresponding to a Specific Activity of 500,000 IU/mg.
Purity: > 95% by SDS-PAGE.BP000140-CYT-378: Recombinant Mouse Interleukin-17 (IL-17) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant induction of IL-6 production in cultured mouse NIH 3T3 fibroblasts was found to be 0.4 ng/ml, corresponding to a specific activity of 2,500,000 units/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000140-CYT-542: Recombinant Rat Interleukin-17 (IL-17) Protein
Source: E. coli-derived.
Rat IL-17A is fully biologically active when compared to standards via dose-dependent induction of IL-6 production in cultured mouse NIH 3T3 fibroblasts. The ED50 for recombinant rat IL-17A in this assay was 30 ng/ml. The Specific Activity is 33333.33 units/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000140-CYT-662: Recombinant Human Interleukin-17 (IL-17) Protein, His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.